# Ezetimibe for Patients With Chronic Hepatitis D

> **NCT03099278** · PHASE2 · UNKNOWN · sponsor: **Ziauddin Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Hepatitis D

## Interventions

- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT03099278
- **Lead sponsor:** Ziauddin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03099278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03099278, "Ezetimibe for Patients With Chronic Hepatitis D". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03099278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*